Skip to main content
Erschienen in: Journal of Hematology & Oncology 1/2010

Open Access 01.12.2010 | Letter to the Editor

An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China

verfasst von: Bao-An Chen, Zhi-Hu Huang, Xiao-Ping Zhang, Jian Ou-Yang, Jian-Yong Li, Yong-Ping Zhai, Xue-Mei Sun, Yan-Li Xu, Qin Lu, Jian-Min Wang, Dong Li, Hui Liao, Zhi-Xiang Shen, Yan-Yan Wang, Xiao-Jing Yu, Hui Ye, Li-Ying Zhuang

Erschienen in: Journal of Hematology & Oncology | Ausgabe 1/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

There has been little literature about leukemia epidemiology in Nanjing in recent years. We aimed to explore the incidence rate, gender and age distribution of leukemia in Nanjing using the leukemia database of the city.

Results

The average yearly incidence rate of leukemia was 3.68/105 during 2003 - 2007 in Nanjing. There were no significant difference in gender (x2 = 3.266, p > 0.05) or seasons (x2 = 11.36, p > 0.05). The incidence rate was the highest in group aged 80~ years (18.64/105). AML accounted for approximately 36.8% of all leukemias.

Conclusions

The incidence rate of leukemia, especially in the aged population, was relatively high in Nanjing. Leukemia is the major malignant tumor in children. Therefore, more attention should be paid to leukemia in children and the aged people.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1756-8722-3-21) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Bao-An Chen, Zhi-Hu Huang and Xiao-Ping Zhang collected the data and contributed to analysis and writing. Jian Ou-Yang, Jian-Yong Li, Yong-Ping Zhai, Xue-Mei Sun, Yan-Li Xu, Qin Lu, Jian-Min Wang, Dong Li, Hui Liao, Zhi-Xiang Shen, Yan-Yan Wang collected the data. Xiao-Jing Yu, Hui Ye, Li-Ying Zhuang did the statistical analyses.
Abkürzungen
FAB
French-American-British Cooperation Group
ALL
acute lymphocytic leukaemia
AML
acute myeloid/myelogenous leukemia
CLL
chronic lymphocytic leukemia
CML
chronic myelocytic leukemia
AUL
acute unclassificatied leukemia.

To the Editor

Nanjing, an ancient capital and the second largest city in southeast China, enjoys a worldwide reputation for its long history and splendid culture. Little has been reported regarding leukemia epidemiology of the city in recent years. The present study was to investigate the leukemia incidence rate in Nanjing during 2003-2007, which may be of help to further leukemia etiology research.
The leukemia data were collected from all hospitals which are capable of making a definite diagnosis of leukemia. We diagnosed leukemia by blood test, bone marrow puncture, histochemical staining and typing and classified by the "French American British" classification. The population data were provided by Nanjing Public Security Bureau and Nanjing Statistical Yearbook in 2007. There were 1,095 cases of various types of leukemia, while the total population in Nanjing during 2003-2007 was 29.7603 million, so the overall average annual incidence rate of leukemia was 3.68/105 and the age-standardized incidence rate was 3.47/105. The result was higher than that of the entire nation (2.76/105) [1], but lower than that in some other cities in China, such as: Shenyang(4.83/105) [2] and Tianjin during 1981-2000(4.71/105) [3]. Moreover, compared with the whites' leukemia incidence rate (12.8/105), it was lower.
Table 1 shows incidence rates of all types of leukemia in every age group in Nanjing during 2003 to 2007. The leukemia incidence rate in old age groups was generally high, and reached to the peak in group aged 80~ years(18.64/105), but this was still lower than the highest rate in Shenyang-the group aged 75~ years (35.76/105) [2]. Although the incidence rate of leukemia in children was lower than that in the old age group, leukemia accounted for a big proportion in the child malignant tumors [2, 4], therefore, leukemia has become the children's primary malignant tumor. The possibe explanation was bad internal environment's stable of hemopoiesis system in children, the hereditary factors, prenatal exposure to hazard factors of leukemia (X-ray, diesel oil, chemical fertilizer) and so on [5]. Other research presumed childhood leukemia was related with poor immunity and high birth weight [6].
Table 1
Leukemia subtype incidence between 2003 to 2007 for different age groups in Nanjing, China
Age (year)
Rate(1/105)
 
AML
ALL
AUL
CLL
CML
Other
Total
0~
0.49
2.95
0.49
0
0
0
3.93
1~
0.23
3.60
0.46
0
0.12
0
4.41
5~
0.48
1.51
0.14
0.07
0.14
0
2.34
10~
0.77
0.68
0.14
0.1
0
0.05
1.74
15~
0.43
1.06
0.09
0
0.26
0.04
1.87
20~
1.15
0.92
0.15
0.04
0.42
0.15
2.85
25~
0.75
0.37
0
0.04
0.45
0
1.61
30~
0.56
0.41
0.09
0.03
0.38
0.03
1.50
35~
0.98
0.26
0.2
0.1
0.85
0.07
2.46
40~
1.42
0.49
0.49
0.31
1.29
0.04
4.03
45~
1.50
0.63
0.17
0.17
0.75
0.04
3.25
50~
2.06
0.89
0.33
0.67
1.17
0.17
5.29
55~
1.53
1.05
0.32
0.97
1.53
0.32
5.73
60~
3.18
0.73
0.64
0.54
1.54
0.09
6.72
65~
3.25
1.12
0.91
2.23
0.91
0.30
8.73
70~
4.83
0.94
0.54
1.61
1.61
0.67
10.20
75~
4.68
1.49
1.28
4.68
2.34
0.43
14.88
80~
7.99
0
0.44
6.21
3.11
0.88
18.64
85~
2.55
1.27
2.55
3.82
3.82
1.27
15.29
Total
1.35
0.81
0.27
0.41
0.73
0.11
3.68
composition ratio(%)
36.8
22.1
7.3
19.7
11.2
2.9
 
Interestingly, AML accounted for approximately 25% of all leukemias in adults and 15%-20% in patients age ≤ 15 years in the Western world[7], which were both much lower than 36.8% in our research. The incidence rates of all types of leukemia especially non-AML types were lower in Nanjing.
The composition ratio of different subtypes of AML were: M2(36.17%), M3(26.60%), M5(11.35%), M4(10.28%), M1(6.74%), M6(4.96%), M7(2.13%), M0(1.77%), respectively. These were similar to the reports in the literature [8, 9].
By chi-square test, no significant difference was found between genders (x2 = 3.266, p > 0.05) or among seasons (x2 = 11.36, p > 0.05). And the 5-year incidence rate is relatviely stable.
Current study has provided detailed information of the leukemia epidemiology in Nanjing during the period 2003-2007. Long-term follow-up investigations are needed for better understanding of characteristics of leukemia in Nanjing, including etiology, survival and risk indicators, which may lend support to the corresponding protocols for prevention and intervention.

Acknowledgements

We thank Nanjing Public Security Bureau for providing the population figures. This work was also supported by grants from Nanjing Medical Science and Technology Development Fundation(No. ZKX08015).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

Bao-An Chen, Zhi-Hu Huang and Xiao-Ping Zhang collected the data and contributed to analysis and writing. Jian Ou-Yang, Jian-Yong Li, Yong-Ping Zhai, Xue-Mei Sun, Yan-Li Xu, Qin Lu, Jian-Min Wang, Dong Li, Hui Liao, Zhi-Xiang Shen, Yan-Yan Wang collected the data. Xiao-Jing Yu, Hui Ye, Li-Ying Zhuang did the statistical analyses.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Cooperation of entire country leukemia and aplastic anemia epidemiology investigation: Leukemia epidemiology investigation of the entire country. Journal of Chinese Academy of Medical Science. 1992, 14: 12-17. Cooperation of entire country leukemia and aplastic anemia epidemiology investigation: Leukemia epidemiology investigation of the entire country. Journal of Chinese Academy of Medical Science. 1992, 14: 12-17.
2.
Zurück zum Zitat Wang HW, Pan XD: An Epidemiology analysis of leukemia incidence in Shenyang. Chinese Journal of Prevention and Control Chronic Non-communicable Disease. 2005, 13: 163-164. Wang HW, Pan XD: An Epidemiology analysis of leukemia incidence in Shenyang. Chinese Journal of Prevention and Control Chronic Non-communicable Disease. 2005, 13: 163-164.
3.
Zurück zum Zitat Chen KX, He M, Dong SF: Study on descriptive epidemiology of leukemia from 1981 to 2000 in Tianjin. Chinese Journal of Oncology. 2004, 31: 424-426. Chen KX, He M, Dong SF: Study on descriptive epidemiology of leukemia from 1981 to 2000 in Tianjin. Chinese Journal of Oncology. 2004, 31: 424-426.
4.
Zurück zum Zitat Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E, Kamps WA: Leukemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. European Journal of Cancer. 2006, 42: 2019-2036. 10.1016/j.ejca.2006.06.005.CrossRefPubMed Coebergh JW, Reedijk AM, de Vries E, Martos C, Jakab Z, Steliarova-Foucher E, Kamps WA: Leukemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. European Journal of Cancer. 2006, 42: 2019-2036. 10.1016/j.ejca.2006.06.005.CrossRefPubMed
5.
Zurück zum Zitat Meinert R, Kaatsch P, Kaletsch U, Krummenauer F, Miesner A, Michaelis J: Childhood Leukemia and Exposure to Pesticides: Results of a Case-control Study in Northern Germany. European Journal of Cancer. 1996, 32A: 1943-1948. 10.1016/0959-8049(96)00231-6.CrossRefPubMed Meinert R, Kaatsch P, Kaletsch U, Krummenauer F, Miesner A, Michaelis J: Childhood Leukemia and Exposure to Pesticides: Results of a Case-control Study in Northern Germany. European Journal of Cancer. 1996, 32A: 1943-1948. 10.1016/0959-8049(96)00231-6.CrossRefPubMed
6.
Zurück zum Zitat Petridou E, Dalamaga M, Mentis A: Evidence supporting the infectious aetiology of childhood leukemia: the role of low herd immunity. Cancer Causes Control. 2001, 12: 645-652. 10.1023/A:1011255825887.CrossRefPubMed Petridou E, Dalamaga M, Mentis A: Evidence supporting the infectious aetiology of childhood leukemia: the role of low herd immunity. Cancer Causes Control. 2001, 12: 645-652. 10.1023/A:1011255825887.CrossRefPubMed
7.
Zurück zum Zitat Smith MA, Ries LAG, Gurney JG: Cancer incidence and survival among children and adolescents: United States SEER Progam 1975-1995. Leukemia. Edited by: Ries LAG, Smith MA, Gurney JG. 1999, NIH Pub. No. 99-4649. Bethesda (MD): National Cancer Institute, SEER Program, 17-34. Smith MA, Ries LAG, Gurney JG: Cancer incidence and survival among children and adolescents: United States SEER Progam 1975-1995. Leukemia. Edited by: Ries LAG, Smith MA, Gurney JG. 1999, NIH Pub. No. 99-4649. Bethesda (MD): National Cancer Institute, SEER Program, 17-34.
8.
Zurück zum Zitat Xiang D, Shen JX, Huang YZ: Analysis on data of acute leukemia epidemiology in our hospital during 22 years. Journal of Navel General Hospital of P.L.A. 2005, 18: 99-100. Xiang D, Shen JX, Huang YZ: Analysis on data of acute leukemia epidemiology in our hospital during 22 years. Journal of Navel General Hospital of P.L.A. 2005, 18: 99-100.
9.
Zurück zum Zitat The cooperation group of National leukemia and aplastic anemia epidemiological investigation: The investigation of National leukemia incidence. Acta Academiae Medicine Sinicae. 1992, 14: 12-19. The cooperation group of National leukemia and aplastic anemia epidemiological investigation: The investigation of National leukemia incidence. Acta Academiae Medicine Sinicae. 1992, 14: 12-19.
Metadaten
Titel
An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China
verfasst von
Bao-An Chen
Zhi-Hu Huang
Xiao-Ping Zhang
Jian Ou-Yang
Jian-Yong Li
Yong-Ping Zhai
Xue-Mei Sun
Yan-Li Xu
Qin Lu
Jian-Min Wang
Dong Li
Hui Liao
Zhi-Xiang Shen
Yan-Yan Wang
Xiao-Jing Yu
Hui Ye
Li-Ying Zhuang
Publikationsdatum
01.12.2010
Verlag
BioMed Central
Erschienen in
Journal of Hematology & Oncology / Ausgabe 1/2010
Elektronische ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-3-21

Weitere Artikel der Ausgabe 1/2010

Journal of Hematology & Oncology 1/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.